Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 623, pseudogene (RN7SL623P)
- Target
- RN7SL623P
- Molecular classification
- Pseudogene, Long non-coding RNA pseudogene (processed), Non-coding RNA (defunct/truncated), Other
01
Overview
RNA, 7SL, cytoplasmic 623, pseudogene (RN7SL623P) is a processed **pseudogene** within the human genome that shares sequence similarity with 7SL RNA, the RNA component of the signal recognition particle (SRP)[1][3]. Pseudogenes like RN7SL623P result from the reverse transcription of RNA back into the genome but lack the regulatory elements or complete coding sequence required for gene expression; thus, they are generally considered non-functional genomic elements[3]. While some pseudogenes in other gene families can act as regulatory RNAs, there is no evidence that RN7SL623P is expressed or has any biological or clinical function. It is not considered a receptor, enzyme, therapeutic target, or biomarker.
- Other names
- RN7SL623P7SL RNA pseudogene 623RNA, 7SL, cytoplasmic 623, pseudogene
02
Mechanism of action
Not applicable
03
Biological functions
None established for this pseudogene[1][3].The parental/gene family 7SL RNA is involved in signal recognition particle (SRP) assembly, protein targeting, and retroviral assembly, but this pseudogene does not participate in these functions[5][7].Other
04
Disease associations
None established for RN7SL623P itself[3].Some relatives of pseudogenes (in general) can regulate genes by acting as miRNA sponges or ceRNAs, impacting cancer or other diseases, but no evidence exists for RN7SL623P[4].
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 623, pseudogene (RN7SL623P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 623, pseudogene (RN7SL623P).